Clinical Trials Browser

Withdrawn × Endometrial Neoplasms × pembrolizumab × Clear all

NCT05419817 2023-02-27

Pembrolizumab With Sitravatinib in Recurrent Endometrial Cancer and Other Solid Tumors With Deficient Mismatch Repair System

Phase 2 Withdrawn

Endometrial Neoplasms

NCT04611139 2022-03-02

Pilot Trial of SP-2577 Plus Pembrolizumab in Select Gynecologic Cancers

Phase 1 Withdrawn

Endometrial Neoplasms

NCT04197219 2020-11-05

Pembrolizumab With Axitinib in Recurrent Endometrial Cancer

Phase 2 Withdrawn

Endometrial Neoplasms